Senior Support Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 355 Mine Rd, 355 Mine Rd, Midway, FL 32343 Phone: 850-597-7865 Fax: 850-580-1017 |
Therapeutic Touch Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 350 N Charles Willis Dr, Midway, FL 32343 Phone: 850-694-7555 |
Big Bend Community Intervention Center Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 155 Slash Cir, Midway, FL 32343 Phone: 850-508-1870 Fax: 850-539-9303 |
Allen Counseling Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1724 Ml King Blvd, Midway, FL 32343 Phone: 850-294-5470 Fax: 850-809-9609 |
Building Better Families Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 141 Hilltop Dr, Midway, FL 32343 Phone: 850-570-4874 |
News Archive
BD (Becton, Dickinson and Company), a leading global medical technology company, announced today the launch in the UK and Ireland of BD Micro-Fine Ultra with 5-bevel needle technology, clinically demonstrated to improve injection comfort for diabetes patients, and enhancing the injection advantages of the current BD Micro-Fine+ Pen Needle.
For 80 years it has been accepted that early life began in a 'primordial soup' of organic molecules before evolving out of the oceans millions of years later. Today the 'soup' theory has been over turned in a pioneering paper in BioEssays which claims it was the Earth's chemical energy, from hydrothermal vents on the ocean floor, which kick-started early life.
A research team led by the National Neuroscience Institute has uncovered a novel function of the Amyloid Precursor Protein (APP), one of the main pathogenic culprits of Alzheimer's disease. This discovery may help researchers understand how the protein goes awry in the brains of Alzheimer's disease patients, and potentially paves the way for the development of innovative therapeutics to improve the brain function of dementia patients.
With the prospect of health-care reform still looming, pharmaceutical and biotech companies face tremendous pressure to keep the costs of their products down.
› Verified 3 days ago